Categories: BioTechBuildingInformation
Location: United Kingdom, England, London
Investors 1
Funding Rounds 1
| Date | Series | Amount | Investors |
| 07.12.2021 | Series A | $53M | - |
Mentions in press and media 5
| Date | Title | Description |
| 26.07.2024 | Leading innovation: 10 promising European startups focusing on biopharmaceuticals | Biopharmaceuticals, often known as bio-pharma, represent a dynamic sector within the pharmaceutical industry that uses biological processes to develop drugs and therapies. Unlike traditional pharmaceuticals, which are typically synthesized ... |
| 07.12.2021 | ATP Launches Adendra Therapeutics, a New Kind of Immunotherapy Company Deploying Novel Insights into Dendritic Cell Biology, with $53M Series A | Co-founded with renowned immunologist Professor Caetano Reis e Sousa of the Francis Crick Institute |
| 07.12.2021 | ATP Launches Adendra Therapeutics, a New Kind of Immunotherapy Company Deploying Novel Insights into Dendritic Cell Biology, with $53M Series A | Co-founded with renowned immunologist Professor Caetano Reis e Sousa of the Francis Crick Institute
First UK-based ATP portfolio company
NEW YORK and LONDON, December 7, 2021—ATP (Apple Tree Partners), a leader in life sciences venture ca... |
| 07.12.2021 | Apple Tree Partners breaks into UK with biotech Adendra Therapeutics launch, $53M series A raise | Apple Tree Partners has picked its first U.K.-based venture to launch: Adendra Therapeutics, an immunotherapy company focused on dendritic cell biology to treat cancers and autoimmune diseases.
Adendra eked out $53 million in a series A fin... |
| 07.12.2021 | Apple Tree Partners breaks into UK with biotech Adendra Therapeutics launch, $53M series A raise | Apple Tree Partners has picked its first U.K.-based venture to launch: Adendra Therapeutics, an immunotherapy company focused on dendritic cell biology to treat cancers and autoimmune diseases.
RELATED: ATP fuels Marengo with $80M for battl... |
Reviews 0
